- Results for the Year ended 31 December 2023
- Notice of Results and Investor Presentation
- Eroxon to be available on prescription
- Trading Update
- Appointment of Joint Corporate Broker
- Director/PDMR Dealing
- Remuneration of Non-Exec Directors & Voting Rights
- Futura Medical extends collaboration with Cooper
- Appointment of Roy Davis as Non-Executive Director
- Total Voting Rights
More ▼
Key statistics
As of last trade, Futura Medical PLC (FUM:LSE) traded at 35.21, 51.22% above the 52 week low of 23.28 set on Dec 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 36.50 |
---|---|
High | 36.50 |
Low | 34.05 |
Bid | 35.05 |
Offer | 36.45 |
Previous close | 35.50 |
Average volume | 1.20m |
---|---|
Shares outstanding | 301.45m |
Free float | 202.32m |
P/E (TTM) | -- |
Market cap | 107.01m GBP |
EPS (TTM) | -0.0219 GBP |
Data delayed at least 20 minutes, as of Apr 19 2024 09:20 BST.
More ▼